FR5429M - - Google Patents

Info

Publication number
FR5429M
FR5429M FR55970A FR55970A FR5429M FR 5429 M FR5429 M FR 5429M FR 55970 A FR55970 A FR 55970A FR 55970 A FR55970 A FR 55970A FR 5429 M FR5429 M FR 5429M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR55970A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR5429M publication Critical patent/FR5429M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR55970A 1965-05-26 1966-04-01 Expired FR5429M (US20020051482A1-20020502-M00012.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2242365A GB1066669A (en) 1965-05-26 1965-05-26 Pharmaceutical preparations

Publications (1)

Publication Number Publication Date
FR5429M true FR5429M (US20020051482A1-20020502-M00012.png) 1967-10-09

Family

ID=10179125

Family Applications (1)

Application Number Title Priority Date Filing Date
FR55970A Expired FR5429M (US20020051482A1-20020502-M00012.png) 1965-05-26 1966-04-01

Country Status (2)

Country Link
FR (1) FR5429M (US20020051482A1-20020502-M00012.png)
GB (1) GB1066669A (US20020051482A1-20020502-M00012.png)

Also Published As

Publication number Publication date
GB1066669A (en) 1967-04-26

Similar Documents

Publication Publication Date Title
FI45216B (US20020051482A1-20020502-M00012.png)
JPS4324467Y1 (US20020051482A1-20020502-M00012.png)
BE675324A (US20020051482A1-20020502-M00012.png)
JPS4428313Y1 (US20020051482A1-20020502-M00012.png)
FI44174B (US20020051482A1-20020502-M00012.png)
JPS437412Y1 (US20020051482A1-20020502-M00012.png)
JPS45767Y1 (US20020051482A1-20020502-M00012.png)
JPS503513B1 (US20020051482A1-20020502-M00012.png)
JPS45268Y1 (US20020051482A1-20020502-M00012.png)
BE675943A (US20020051482A1-20020502-M00012.png)
BE675542A (US20020051482A1-20020502-M00012.png)
BE664086A (US20020051482A1-20020502-M00012.png)
BE676335A (US20020051482A1-20020502-M00012.png)
BE678361A (US20020051482A1-20020502-M00012.png)
BE678362A (US20020051482A1-20020502-M00012.png)
BE690329A (US20020051482A1-20020502-M00012.png)
BE686597A (US20020051482A1-20020502-M00012.png)
BE682033A (US20020051482A1-20020502-M00012.png)
BE676186A (US20020051482A1-20020502-M00012.png)
BE676055A (US20020051482A1-20020502-M00012.png)
BE676004A (US20020051482A1-20020502-M00012.png)
BE675944A (US20020051482A1-20020502-M00012.png)
NL6607096A (US20020051482A1-20020502-M00012.png)
BE675920A (US20020051482A1-20020502-M00012.png)
BE675901A (US20020051482A1-20020502-M00012.png)